Pinned Tweet
"A publicly accessible metadata of the 15 databases available to NeuroGEN researchers across North America, Europe, Asia, Oceania to facilitate the RWD use for assessment of disease burden and development of current and future treatments for neurological and mental disorders."
Daniel Tsai retweeted
Our study published in @LancetRH_WPac analyzed post-COVID-19 #sequelae across Asia–Pacific populations, revealing diverse short-term multi-organ #complications and elevated #mortality, especially in patients aged >65 or with #multimorbidity, emphasizing the need for targeted monitoring and #reinfection prevention.
Our paper:
sciencedirect.com/science/ar…
The team:
@Ranzhang_hku
@IVANCHLAM
@Yi_Chai18 of @ShenzhenUni
Xinyi Liu
@_GeorgeTan & @jenni_ilomaki & Professor J. Simon Bell of @CentMedUseSafet @MonashPharm
Daniel Hsiang-Te Tsai & Prof. Edward Chia-Cheng Lai & Chin-Yao Shen & Michael Chun-Yuan Cheng of @NCKU_official
Prof. Jeff Harrison & @amyhychan of @FMHS_UoA
Dr. Bin Hong of @skku_official
Prof. Ju-Young Shin of @SNU_Pharm @SeoulNatlUni
Dr. Shahab Abtahi & @OKlungel of @UUUIPS @UniUtrecht
@ChuiCeline
@snowly12191
@Esther_CSMPRHKU
@hkumed
@HKU_FMPC
@HkuPharm
@CSMPR_HKUPharm
#HKU #HKUMed #FMPC #PrimaryCare #HKUPharm #CSMPR #COVID19 #PostCOVID #RetrospectiveCohort #PropensityScore #ElectronicMedicalRecord #EMR
Our study shows SGLT-2 inhibitors reduce the risk of all-cause mortality (HR: 0.77) and hepatic decompensation (HR: 0.89) in patients with type 2 diabetes and compensated cirrhosis. @BMCMedicine
doi.org/10.1186/s12916-026-0…
Daniel Tsai retweeted
Talking about CCW during educational session this ACPE.
Always find something new when I approach this methodology every time.
Daniel Tsai retweeted
New in #ASNKidney360: SGLT2 inhibitors were associated with lower nephrolithiasis risk compared to DPP4i and GLP-1RA in patients with diabetes. Read more: kidney.pub/KID0981
Daniel Tsai retweeted
Excited to share that our study has just been published in the #EuropeanHeartJournal! This is a nationwide case-crossover study to examine whether short-term increases in anticholinergic burden(#OHCA).
academic.oup.com/eurheartj/a…
Daniel Tsai retweeted
New Article: Epidemiology and Burden of Illness of Lennox-Gastaut Syndrome in Taiwan: A Retrospective Cohort Study ift.tt/erN5uLc #PEM #FOAMed #PEMUPDATES
Daniel Tsai retweeted
"Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan", has been published by our international team! Read ascpt.onlinelibrary.wiley.co…
No significant difference in IBD risk between SGLT2i vs DPP4i
Null results are just as essential, they refine expectations, guide better science, and prevent overhype.
authors.elsevier.com/c/1lqE7…
The burden of Neonatal Invasive Candidiasis in Low- and Middle-Income Countries: a systematic review and meta-analysis.
✅ Just Accepted
🔗 bit.ly/3ZXqy9N
1
1
55
Happy to get this piece published. A hard work emulating three trials to inform drug repurposing.
@Lai_Edw @albert_ch1210
#PHDCenter
SGLT2 inhibitors and chronic kidney disease:
SGLT2 inhibitors may be considered to reduce risk of chronic kidney disease mineral and bone disorders (CKD-MBD) in patients with type 2 diabetes mellitus and stage 1–3 CKD.
➡️ cmaj.ca/lookup/doi/10.1503/c…
We found that antipsychotic augmentation was associated with a reduced incidence of suicide attempt. However, after using the clone-censor-weight approach to control for time-lag bias, we no longer found any association of antipsychotic augmentation with reduced risks of suicide.
Daniel Tsai retweeted
We’re analyzing (early teaser) where the U.S. really gets its final drug dosages from—and early data is eye-opening.
This is why drug supply chains must be protected from strain—including #tariffs.
Global thinking is essential here.















